Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Revenue from awards $ 0 $ 97,323 $ 0 $ 881,705
Operating expenses:        
Research and development 4,108,190 8,695,641 9,894,068 30,681,684
General and administrative 4,073,266 5,277,090 14,144,557 16,190,684
Litigation Settlement 0 0 5,000,000 0
Total operating expenses 8,181,456 13,972,731 29,038,625 46,872,368
Operating loss (8,181,456) (13,875,408) (29,038,625) (45,990,663)
Other income (expense), net:        
Other income (expense), net 77,712 12,033,031 (324,322) 11,790,328
Interest income (expense), net (541,889) (391,867) (1,491,137) (1,439,587)
Change in fair value of derivative liability 0 472,143 0 670,143
Foreign currency exchange gain (loss), net (136,087) (414,048) (613,766) (409,914)
Other income (expense), net (600,264) 11,699,259 (2,429,225) (10,610,970)
Net loss $ (8,781,720) $ (2,176,149) $ (31,467,850) $ (35,379,693)
Earnings Per Share, Basic $ (0.07) $ (0.02) $ (0.25) $ (0.29)
Earnings Per Share, Diluted $ (0.07) $ (0.02) $ (0.25) $ (0.29)
Weighted Average Number of Shares Outstanding, Basic 125,268,381 125,209,985 125,255,927 122,234,847
Weighted Average Number of Shares Outstanding, Diluted 125,268,381 125,209,985 125,255,927 122,234,847
Comprehensive loss:        
Net loss $ (8,781,720) $ (2,176,149) $ (31,467,850) $ (35,379,693)
Other comprehensive income (loss):        
Change in unrealized gain (loss) on marketable debt securities (87,554) (3,513) (144,429) (8,967)
Total other comprehensive income (loss) (87,554) (3,513) (144,429) (8,967)
Total comprehensive loss $ (8,869,274) $ (2,179,662) $ (31,612,279) $ (35,388,660)